摘要
目的 :探讨干扰素驱动雾化吸入治疗毛细支气管炎的疗效。方法 :毛细支气管炎患儿 110例 ,均给予抗感染、氧疗、对症等综合治疗。随机分为两组 ,驱动雾化吸入治疗组 64例 ,加用干扰素驱动雾化吸入治疗 ,对照组不用雾化吸入 ,其他均同。根据喘憋消失时间、音吸收时间、住院天数比较两组治疗后的临床疗效。结果 :干扰素驱动雾化吸入治疗组较对照组喘憋消失时间显著缩短 (P <0 .0 1) ,音吸收时间显著缩短 (P <0 .0 5 ) ,住院天数显著缩短 (P <0 .0 1)。结论
To evaluate the efficacy of interferon inhalation by PARI inhaler boy with bronchiolitis, 110 children were randomly divided into two groups. Group 1 included 64 cases who received interferon inhalation by PARI inhaler boy(made in Germany)and the other 46 patients who didn't received interferon by PARI inhaler boy served as group 2. The effects were compared between the two groups in term of wheezing rale disappearance time, rale absorbing time and hospital stay time. Our results showed that wheezing rale disappearance time in group 1 was shorter than that in group 2( t=6.143, P<0.01 ); rale absorbing time in group 1 was significantly shorter than that in group 2 ( t=2.03, P<0.05 ); hospital stay time in group 1 was significantly shorter than that in group 2( t=3.195, P<0.0 ). It is concluded that interferon inhalation by PARI inhaler boy is an effective auxiliary treatment for bronchiolitis.
出处
《药物流行病学杂志》
CAS
2001年第1期8-9,共2页
Chinese Journal of Pharmacoepidemiology
关键词
干扰素
毛细支气管炎
驱动雾化
治疗
Bronchiolitis
Interferon
Inhalation therapy
Children